Forming effective collaborations is important to IGHI. By working in partnership with leaders in their fields, IGHI can make better-informed decisions and obtain a broader understanding of the issues facing global health today.

Our Visiting/Adjunct Professors and Honorary Fellows are listed below:

Our affiliates

Dr Hanan Mohamed Al Kuwari, Minister of Public Health and Managing Director, Hamad Medical Corporation

 Dr Hanan Mohamed Al Kuwari

IGHI Visiting Professor

Her Excellency Dr Hanan Mohamed Al Kuwari is the Minister of Public Health for the State of Qatar and is also the Managing Director of Hamad Medical Corporation (HMC), the main national provider of hospital care.

She has been Managing Director of HMC since 2007 and has led the Corporation in transforming into an integrated academic health system that has achieved numerous international accreditations and awards.

H.E Dr Hanan Mohamed Al Kuwari is a member of the Board of Sidra Medical & Research Center, the Joint Commission International (JCI) Middle East Advisory Council, the Association of Academic Health Centers International (AAHCI) Steering Committee and the Institute of Global Health Innovation and Advisory Board Member of the World innovation Summit for Health (WISH). She is Chairperson of the Qatar Bio-Bank Board.

She holds a PhD in healthcare management from Brunel University in the UK and is a visiting professor at Imperial College in London and has received several awards in recognition of her achievements. She is published in various international journals and often speaks at major international conferences. 

Dr Faleh Mohamed Hussain Ali, Assistant Secretary General for Policy Affairs, Supreme Council Of Health

Dr. Faleh Mohamed Hussain AliIGHI Visiting Professor 

Dr. Faleh Mohamed Hussain Ali is Assistant Secretary General for Policy Affairs at the Supreme Council of Health, Qatar’s highest health authority. He is also Acting Chief Executive Officer of the National Health Insurance Company, Qatar’s public agency responsible for the implementation and administration of a new national health insurance scheme.

Dr. Faleh has a strong academic interest. He is Visiting Scientist at the Harvard T.H. Chan School of Public Health, and nearing completion of his doctorate of philosophy at Imperial College London. He serves on several academic and scientific groups at Qatar University, Qatar Foundation, and Imperial College London. His main research interests include health financing, and health reform impact assessments.

Prior to turning to administration, Dr. Faleh held several health management and clinical posts in Qatar. After working as an orthopedic surgeon and emergency physician, he served as hospital chief executive officer in the public sector. Dr. Faleh holds a Master of Science in Health Management from Imperial College London, and a Bachelor Degree in Medicine from the Royal College of Surgeons in Ireland.

John Appleby, Chief Economist, Health Policy, The Kings Fund

John ApplebyIGHI Visiting Professor 

John Appleby has been Chief Economist at The King’s Fund since 1998. He has worked in the National Health Service in Birmingham and London, and as senior lecturer at the universities of Birmingham and East Anglia.

John has published widely on a range of health care finance and economic issues in books, academic journals, reports, magazines and newspapers. He contributes regularly to the British Medical Journal on economic issues. John has also acted as an adviser to the UK government and parliament in various capacities.
As well as his post at The King’s Fund, John is a Visiting Professor at the Department of Economics at City University, where he teaches and carries out joint research with colleagues in the City Health Economics Centre.

Professor Sir Sabaratnam Arulkumaran, Head Of Obstetrics & Gynaecology, St George’s University of London

Professor Sir Sabaratnam Arulkumaran

IGHI Visiting Professor

Sir Sabaratnam is Head of obstetrics and gynaecology at St George's University of London and President-Elect of the International Federation of Obstetrics and Gynaecology.

His current research and clinical interests are in understanding and improving the quality of life for women and newborn babies. He has been in clinical practice for 37 years and in research and teaching for 25 years and joined St George’s, University of London as a professor and then became head of obstetrics and gynaecology.

Before this, he held posts at a number of high-profile institutions including the National University of Singapore, the University of Nottingham, the Asia and Oceania Federation of Obstetrics and Gynaecology, and theInternational Federation of Obstetrics and Gynaecology

Robert J Bell, Chief Executive Officer, Royal Brompton & Harefield NHS Foundation Trust

Robert J BellIGHI Visiting Professor

Mr Robert J Bell joined the Trust as chief executive in March 2005 from the William Osler Health Centre, Ontario, Canada, where he was president and chief executive officer.

He has over 40 years international experience in hospital and health services management.

He is a member of the board of directors of Imperial College Health Partners, the Institute of Cardiovascular Medicine and Science. He is also a member of the Board of Directors of Imperial College Academic Health Sciences Centre. Visiting Professor at the Institute of Global Health Innovations, Imperial College and Chairman of the Association of UK University Hospitals.

He has previously held positions as:

  • Vice President, Health Care & Life Sciences Market Sectors, Cap Gemini, Ernst & Young Canada Inc.
  • Partner, Ernst & Young and at KPMG (Peat Marwick), Toronto
  • Vice President, Hilton Universal Hospitals UK Ltd, London
  • Vice President, International Services, Extendicare Inc. (London and Toronto)
  • Executive Director of District Health Councils in the Ministry of Health, Ontario
  • Treasury board officer, Management Board of Cabinet, Government of Ontario
  • Systems engineer, Hospital for Sick Children, Toronto.

Robert has a Bachelor of Applied Science in Industrial Engineering from the University of Toronto and a Master of Public Administration, Queen’s University (Canada)

Dr David Bennett, Former Chairman and Chief Executive Officer, Monitor

David Bennett

IGHI Visiting Professor

Dr Bennett served as the Chief Executive of Monitor, the regulator of the National Health Service (NHS) in England, for five years and was also Chairman during three of those years. In this role, Dr Bennett was responsible for regulating one hundred fifty two NHS trusts with annual revenue of £46 billion. Prior to joining Monitor, Dr Bennett was worked in the Cabinet Office for Prime Minister Tony Blair, as Head of the Number 10 Policy Unit. This followed an eighteen-year career with McKinsey & Company, where he was a senior partner.

For the past three years, Dr Bennett has also served in multiple non-executive or advisory roles. He is Chairman of the Top 10 Partnership Lit, Non-Executive Director and Chairman-designate of GHK Holdings, and Associate Fellow of the Institute for Government. 

Dr Jo Boufford, President of the New York Academy of Medicine

Jo Boufford

IGHI Visiting Professor

Dr. Boufford is Professor Emeritus of Public Service, Health Policy and Management at the Robert F. Wagner Graduate School of Public Service and Clinical Professor of Pediatrics at New York University School of Medicine. She is Co-Director of the National Program Office of the Robert Wood Johnson Foundation Health and Society Scholars Program. She served as Dean of the Robert F. Wagner Graduate School of Public Service at New York University from June 1997 to November 2002. Prior to that, she served as Principal Deputy Assistant Secretary for Health in the U.S. Department of Health and Human Services (HHS) from November 1993 to January 1997, and as Acting Assistant Secretary from January 1997 to May 1997. While at HHS, she served as the U.S. representative on the Executive Board of the World Health Organization (WHO) from 1994–1997.

Dame Ruth Carnall, Former Chief Executive, NHS London and Strategic Advisor On Health to The Mayor Of London

Dame Ruth CarnallIGHI Adjunct Professor 

Dame Ruth has over 30 years of experience in healthcare with 20 as a chief executive in the NHS covering acute hospitals, mental health and community services and health authorities.

She has worked in senior positions at a local, regional and national level covering operational, strategic and policy roles. Over the last 7 years, Ruth has been responsible for the NHS in London as Chief Executive of NHS London. In this capacity, she has overseen an extensive programme of performance improvement and strategic change.

Prior to joining NHS London, Ruth worked as an independent consultant with public and private sector clients including Department of Health, Monitor, Health Authorities, NHS Trusts and Glaxo as well as the Prime Minister’s Delivery Unit, the Cabinet Office, the Home Office and the Ministry of Justice.
In 2011, Ruth was made a Dame Commander of the British Empire for her achievements in healthcare.

Dr Will Cavendish, Director General, Innovation, Growth and Technology at The Department Of Health

Dr Will Cavendish

IGHI Visiting Professor

Dr Cavendish is responsible for delivering multi-billion pound technology and digital programmes to transform the NHS; for the effective and innovative use medicines, devices and pharmacy via their £16bn budget; for promoting growth, jobs and exports in the digital, genomics and pharma sectors; and for ensuring the secure and effective use of data in the NHS. In previous roles Dr Cavendish was responsible for a range of personal and public health areas that are central to the future health of the nation. These include tackling obesity and overweight, reducing alcohol harm, promoting breastfeeding, promoting greater physical activity, improving children and young people’s public health, and improving dramatically workplace and employee health.

Dr Cavendish previously spent two years as Director of Strategy at the Department of Health. Prior to that he was Senior Policy Advisor in the Prime Minister's Strategy Unit, Special Advisor to the Secretary of State for Education and Skills, and was head of policy for the Labour Party in the run up to the 2001 General Election. He has had a distinguished career as an economist, working for the World Bank and a number of other international agencies, lecturing at Oxford University and Imperial College, and holds a doctorate in economics from Oxford University.

Professor Karl Claxton, Professor of Economics, Centre For Health Economics, University of York

Karl ClaxtonIGHI Visiting Professor

Karl Claxton is a Professor in the Department of Economics and Related Studies at the University of York. He is also a Senior Research Fellow in the Centre for Health Economics, University of York.

He was a Harkness Fellow at the Harvard School of Public Health and from 1999 until 2007 he held an adjunct appointment at Harvard as an Assistant Professor of Health and Decision Sciences.

His research interests encompass the economic evaluation of health care technologies.

He has served as a member of the National Institute for Clinical Excellence Appraisal Committee since 1999. He has represented the committee at a number of appeals and was an expert witness for the Institute during the judicial review in 2007. He is a member of the National Decision Support Unit and continues to contribute to the development of guidance for the appraisal of health technologies for NICE. He is also co-editor of the Journal of Health Economics. 

He received a PhD in Economics, a MSc in Health Economics and a BA in Economics all from the University of York.

Professor Anthony Culyer, Centre for Health Economics, University Of York

Anthony Culyer

IGHI Visiting Professor

Tony has been at York since 1969 where his main roles have been as Assistant Director of the (then) Institute for Social & Economic Research, Head of the Department of Economics & Related Studies, and Pro-Vice-Chancellor and Deputy Vice-Chancellor of the University. He currently holds a part-time chair in Economics at York and is Ontario Research Chair in Health Policy and System Design at the University of Toronto. He was the founding Vice Chair of the National Institute for Health & Clinical Excellence and is a member of the NICE Citizens Council Committee and the NICE International Advisory Committee. He chairs the Policy and Editorial Committees of the Office of Health Economics and until 2010 he also chaired the Research Advisory Council of the Workplace Safety & Insurance Board in Ontario. He is a founding editor of the Journal of Health Economics, a Founding Fellow of the Academy of Medical Sciences, an Honorary Fellow of the Royal College of Physicians, a CBE and has an honorary doctorate from the Stockholm School of Economics.

His current research interests relate to problems in thinking about how equity in health is best achieved and how decisions about cost-effective technologies are best arrived at.

Sir Andrew Dillon, National Institute for Health And Care Excellence (NICE)

Sir Andrew DillonIGHI Visiting Professor

Sir Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.

Ian Dodge, Director, NHS Group, Department of Health

Ian DodgeIGHI Adjunct Professor

Ian is the Director of the NHS Group, a government initiative within the UK Department of Health, which advises Ministers on their stewardship of the NHS. Ian is also Head of Policy Profession where he leads on improving the quality of policy making across the Department of Health.

He was previously the Chief Policy Adviser on Health to the Prime Minister at No 10 Downing Street. Previous posts within the Department of Health were Director of the Policy Unit, Deputy Director for NHS Performance and Head of Primary Medical Care.

Stephen Dorrell, Health Policy Consultant, KPMG

Stephen DorrellIGHI Visiting Professor

Stephen James Dorrell is a former British Conservative politician. He served as the Member of Parliament for Loughborough between 1979 to 1997 and then for Charnwood from 1997 to 2015.

Dorrell most recently served for four years as Chairman of the House of Commons Health Select Committee from 2010 to 2014.

In the 1990s he was a full member of Prime Minister John Major's Cabinet for almost three years, whilst serving as both Secretary of State for National Heritage and then Secretary of State for Health until the 1997 general election. He was also a Patron of the Tory Reform Group.

Since 2014 he has been a consultant with the health and public service practice of KPMG.


Rachel Dunscombe, CEO, NHS Digital Academy

Rachel DunscombeIGHI Visiting Professor 

Rachel Dunscombe is the Director of Salford Royal Group and was appointed as CEO of the NHS Digital Academy. She was previously CIO at Bolton FT and is currently chair of the HIMSS UK Advisory Board. Rachel is working on new research studies to follow the Salford Lung Study and is a member of the KLAS research advisory board. As part of her role at Salford she is delivering the Global Digital Exemplar and two NHS Vanguards. She is also a board member for the ISD network, the north-west professional network for informatics, and a member of US organisation Chime, the professional body for CIOs.

Dr Michael Durkin, National Director of Patient Safety, NHS England

Michael DurkinIGHI Visiting Professor

Dr Mike Durkin is the National Director of Patient Safety at NHS England.  Prior to joining NHS England Mike was the Medical Director of the South of England Strategic Health Authority since 2006. He is the National Clinical Director for Venous Thrombo-Embolism and leads the national VTE Prevention Programme.

He qualified at The Middlesex Hospital and has held research and teaching appointments in London and Bristol. He was appointed to the faculty at Yale University School of Medicine where he was also an Attending Anaesthesiologist. He was Medical Director of Gloucestershire Royal NHS Trust from 1993 to 2002 where he has a consultant post in Anaesthesia. He was appointed as Medical Director and Director of Clinical Quality for Avon, Gloucestershire and Wiltshire Strategic Health Authority in 2002.

Professor Leonard Fass, Former Director of Academic Relations, GE Healthcare

Prof FassIGHI Visiting Professor

Professor Fass has 42 years of experience in medical technology in both R&D and marketing roles mainly in the field of diagnostic imaging. He sits on the Executive Board of the UK Bioengineering Society and on several university advisory boards. He is a reviewer for multiple national and international research funding agencies. For many years he has served on the Business and Industry Advisory Committee to the OECD on Healthcare Policy.

Sir Robert Francis QC. Barrister, Serjeants' Inn Chambers

IGHI Visiting Professor

Robert FrancisSir Robert Francis QC is a renowned expert on medical law, particularly in the area of clinical negligence, medical and mental health treatment and capacity issues, and professional discipline. As a barrister, Sir Robert has appeared in inquiries for a number of NHS scandals, including the Royal Liverpool Children’s Inquiry, which led to the Human Tissue Act 2004, and the Bristol Royal Infirmary Inquiry, which resulted in cardiac surgeons in the UK publishing more data on the performance of doctors and hospitals. Sir Robert has also chaired a number of independent inquiries.

Sir Robert has also served as the president of the Patients Association since November 2013 and is a non-executive board member of the Care Quality Commission since June 2014. Sir Robert was knighted in the 2014 Birthday Honours, is a trustee of the Point of Care Foundation and the Prostate Cancer Research Centre and has been elected to an Honorary Fellowship of the Royal College of Anaesthetists.

Professor Glenn Gibson, Head of Food Microbial Science Unit, University of Reading

Glenn GibsonIGHI Visiting Professor

Professor Gibson has demonstrated significant impact within his profession and work practice as a leader in the field of food microbial sciences. He was responsible for the initiation of the prebiotic concept for gut flora management through diet. The article which originally coined this term was published in 1995 and is currently the most-cited paper in the Agricultural Sciences field of the ISI Essential Science Indicators (>2000 citations).

He is the Founder and a member of the International Scientific Association for Probiotics and Prebiotics (ISAPP). ISAPP provides a forum for researchers and food and biopharma industry professionals to exchange research finding s lead ing to further opportunities for collaboration and exploitation of the research.
He is a Board Member of Clasado Advisory Board, Ganeden, Kellogg’s, Allergy Research Foundation, General Mills and Fugeia.

He has taken part in many high profile public engagement activities including research being covered by television programmes, international news broadcasters and publications.

Peter Goldsbrough, Senior Advisor, The Boston Consulting Group

IGHI Visiting Professor

Peter Goldsbrough recently retired as a Senior Partner and Managing Director at The Boston Consulting Group, where he held a number of global leadership roles. He is now a Senior Advisor to the firm.

At BCG Peter specialised in the leadership of large-scale operational and organisational change with a particular focus in post merger integration. He has supported a number of major multi- national integrations and is an expert in this area.

Peter advises leaders of major organisations in the public and private sectors on all aspects of strategic performance and operational change. He has deep expertise in the healthcare and higher education sectors. His geographic experience covers the UK, Europe, the US, Asia and Australasia. He was previously an NED at NHS London. 

Professor Sian Griffiths, Board Member, Public Health England and Director, Centre for Global Health, Chinese University of Hong Kong

Prof GriffithsIGHI Visiting Professor

Professor Griffiths has demonstrated significant impact within her profession and work practice as a leader in the field of public health.

Sian joined the Chinese University of Hong Kong as Professor of Public Health and Director of the School of Public Health in 2005. She becomes the Chairman of the Department of Community and Family Medicine in 2006. She qualified as a doctor and held a variety of service posts with academic links at international, national, regional and local level within the UK.

She was Chair of the Association for Public Health, Co-founded the UKPHA and was Pr e sident of the UK Faculty o f Public Health of the Royal Colleges of Physicians from 2001-4 having held a wide number of professional positions.

She co-chaired the Hong Kong Government’s expert committee into the SARS epidemic in 2003 as well as the monitoring committee. Since coming to Hong Kong, she has worked with HKSAR Government, public health professional organisations and colleagues across the healthcare and academic systems. Her interests are in developing health policy through public health approaches and in developing public health capacity to promote the public’s health.

She is a member of the UK RAE panel for epidemiology and public health, and is a member of the National Health Authority Board of Qatar. She is an Honorary Professor at Peking University, the School of Public Health, also a Technical Advisor to Public Health research in Shenzhen Center for Disease Control and Prevention.

She remains honorary senior clinical lecturer in the Department of Public Health an d
Primary Care of Oxfor d University with whom the School of Public Health, The Chinese University of Hong Kong maintain links. She plays an active role in public health education and policy development in Hong Kong, including advising the HKSAR Department of Health.

In 2000, she received the OBE for services to publi c health and was made JP by the HKSAR Government in 2010 for her contribution to health in Hong Kong.

Dr David Halpern, Chief Executive, Behavioural Insights Team

Dr HalpernIGHI Visiting Professor 

David Halpern is the Chief Executive of the Behavioural Insights Team and Board Director. He has led the team since its inception in 2010. Prior to that, David was the founding Director of the Institute for Government and between 2001 and 2007 was the Chief Analyst at the Prime Minister’s Strategy Unit. Before entering government, David held tenure at Cambridge and posts at Oxford and Harvard. He has written several books and papers on areas relating to behavioural insights and wellbeing, including Social Capital (2005), the Hidden Wealth of Nations (2010), and co-author of the MINDSPACE report. David has recently written a book about the team entitled Inside the Nudge Unit: How Small Changes Can Make a Big Difference.

Dr Felicity Harvey, Former Director General, Public and International Health

Dr HarveyIGHI Visiting Professor

Dr Felicity Harvey CBE was appointed Director General, Public and International Health in April 2012, retiring in June 2016. Previous roles include Director of the Prime Minister’s Delivery Unit; Head of Medicines, Pharmacy and Industry Group at the Department of Health; Director of Prison Health at HM Prison Service; Head of Quality Management, NHS Executive and Private Secretary to the Chief Medical Officer. 

Felicity qualified in medicine in 1980, specialising in medical microbiology. She was later seconded to Henley Management College to study for an international MBA.

Dr Axel Heitmueller, Managing Director, Imperial College Health Partners

AxelIGHI Visiting Professor

Axel has been involved with Imperial College Health Partners since its conception in 2011 as an Interim Director and joined the Partnership full-time in August 2013 as Director of Strategy and Commerce. As of September 2016 Axel was appointed as Managing Director.

Prior to joining the Partnership, Axel was Executive Director of Strategy and Business Development at Chelsea and Westminster Hospital NHS Foundation Trust. He brings a broad range of experience from academia and central government where he was Deputy Director and Chief Analyst at the Prime Minister’s Strategy Unit in the Cabinet Office and No 10.

Dr Adam Hill, Chief Medical Officer, McLaren Applied Technologies

Adam HillIGHI Visiting Professor

Adam Hill is a dual-qualified Clinician and Mechanical Engineer, with a career built at the interface of Academia, Industry and Health systems. In recent years, he has founded a successful applied research centre, enveloping an R&D programme with expertise in the optimization of novel products and systems, provided strategic advice to global life science companies on behalf of the British Government, and led the medical function in a multinational, publically-listed Health IT brand. 

Recently appointed as the Chief Medical Officer of McLaren Applied Technologies, Adam is focused on applying the company’s deep technical expertise to developing human-centric, data-driven solutions to challenging problems that inhibit the realisation of high quality health outcomes for all.

Adam graduated from Imperial College London as a Medical Doctor with gold medal; during this time, he also earned a PhD in Engineering and attended Business School. Having subsequently graduated from the Royal Military Academy Sandhurst, he received his postgraduate clinical training from the Royal College of Surgeons of England, and professional engineering qualification from the Institution of Mechanical Engineers while in the British Army. In addition, Adam has built a portfolio of over 100 publications, in addition to 12 academic awards and patents.

Phil Hope, Former Minister for Care Services, Department of Health

Phil HopeIGHI Visiting Professor

Phil is the co-director of Improving Care – a company committed to improving the lives of vul nerable and older people. It aims to help health and social care organisations develop excellent and sustainable services that enable older people to become well, live independently, and stay longer in their own homes.

Phil is the former MP for Corby and served in a number of Ministerial roles over seven years (2003-2010). As Minister of State for Care Services in the Department of Health his work included development of the White Paper ‘Building a National Care Service’, the National Dementia Strategy, the National Mental Health Strategy ‘New Horizons’, and the National Autism Strategy.

Professor Clifford Hughes, President Elect, International Society for Quality in Healthcare

Cliff HughesIGHI Visiting Professor

Professor Cliff Hughes is the President-elect of the International Society for Quality in Health Care. Until 31st March 2015 the Chief Executive Officer of the Clinical Excellence Commission, a statutory health corporation established in 2004 to build capacity and design programmes to promote and support improvement in quality and safety for health services across NSW. This appointment follows a 25-year career as a cardiothoracic surgeon in Sydney. He has been chairman or member of numerous state and federal committees associated with quality, safety and research in clinical practice for health care services. He has held various positions in the Royal Australasian College of Surgeons, including Senior Examiner in Cardiothoracic Surgery and member of the College Council. In November 2015 he was awarded the Sir Hugh Devine medal, the highest honour awarded a Fellow in his lifetime Professor Hughes has served on four editorial boards and has published widely in books, journals and conference proceedings on cardiothoracic surgery, quality and safety. He has a particular passion for patient based care, better incident management, quality improvement programmes and the development of clinical leaders. He has received a number of awards for his national and international work including an Alumni Award from the University of NSW. He has led five medical teams to China and has performed cardiac surgery in Hong Kong, Singapore, Malaysia, India and Bangladesh. In 1998, he was made an Officer in the Order of Australia (AO) in recognition of his contributions and “service to cardiac surgery, international relationships and the community”. In June 2014, the University of NSW conferred upon him the degree of Doctor of Science, its highest academic award

Sir Thomas Hughes-Hallett, Chair, Chelsea and Westminster Hospital NHS Foundation Trust

Thomas Hughes-HallettIGHI Adjunct Professor

Former barrister, banker and Chief Executive of Marie Curie Cancer Care, Sir Thomas is the Non-Executive Chair of Cause4 - a social business creating pioneering programmes and fundraising solutions for the charitable sector - and the Chair of Chelsea and Westminster Hospital NHS Foundation Trust.

Sir Thomas has been author of a number of independent reviews including The Philanthropy Review, a Review of End-of-Life Care for Adults and Children and the 2013 ‘Who Will Care?’ report commissioned by Essex County Council on health and social care strategy in Essex.

He also authored ‘Dying Healed: Transforming End-of-Life Care Through Innovation’ for the 2013 World Innovation Summit for Health.

Trustee of The Esmée Fairbairn Foundation and The King’s Fund, Sir Thomas is also Chairman of the End-of-Life Care Implementation Advisory Board.

Awarded a Knighthood in 2012 and a Beacon Fellowship for Philanthropy Advocacy in 2013, Sir Thomas’s passions are philanthropy, innovation, patient-centred healthcare and choral music.

Professor Robert Istepanian

Prof IstepanianIGHI Visiting Professor

Professor Istepanian is globally recognized as one of the leading authorities and pioneer of the area of mobile healthcare (m-health) and the first scientist to have coined and defined this concept.

After completing his PhD in Electronic and Electrical Engineering from Loughborough University, UK in 1994, he held several academic and research posts in UK and Canada. These included Professor of Data Communications for Healthcare and the founding Director of the Medical Information and Network Technologies Research Centre (MINT) at Kingston University, London, UK (2003-2013).

Senior lectureships in the Universities of Portsmouth, UK (1995-1998) and Brunel University, London (2000-2003). A visiting Professor at St. George’s Medical School, University of London (2007-2009). Associate Professor Ryerson, Univeristy, Toronto and adjunct Professor at the University of West Ontario, Canada (1999-2000). He was also the 2008 Leverhulme distinguished visiting fellow at the Centre for Global e-health Innovation University of Toronto and the University’s Health Network, Canada.

He was awarded the 2009 IEEE award for the best IEEE Transactions and most cited paper from the IEEE Engineering in Medicine and Biology Society for his seminal work and paper on mobile healthcare (m-health) published in 2004. He was also recipient of the IEE Heaviside award in 1999 from the Institution of Electrical Engineering (IEE), UK.

Tim Kelsey, Chief Executive, new Australian Digital Health Agency

Tim KelseyIGHI Visiting Professor

Tim Kelsey is an entrepreneur and leading advocate for a popular knowledge revolution in government and public services and an internationally regarded thought leader in data transparency and digital technology, particularly in health. 

Tim is a senior leader and manager in both public and private sectors. He was founding CEO of Dr Foster, one of the fastest growing businesses in the UK, and now is a main board director of the NHS, one of the world’s largest organisations, where he designs and implements retail digital and information services.

Edward Kiely, Honorary Consultant Paediatric Surgeon, Great Ormond St Hospital for Children

Edward KielyIGHI Adjunct Professor

Edward Kiely has 45 years' experience as a surgeon, with 15,000 operations under his belt.  In 2010, he led a team of surgeons who successfully separated conjoined twins Hassan and Hussein Benhaffaf.  Their separation was a massive undertaking. They shared many organ and bones, which necessitated the division of liver, intestine and bone in a 14-hour operation, involving a medical team, 20 strong. 

Paul Levy, Corporate Advisor, Author, Speaker

Paul LevyIGHI Visiting Professor

Paul F. Levy has had an extensive career as a chief executive and leader of several organizations, from running a world-class teaching hospital to managing the multi-billion dollar clean up of the Boston harbor, hailed as one of the most successful examples of public infrastructure projects in a metropolitan area. He has been an innovative leader, known internationally for pushing the boundaries of transparency in organizational communication and continuous learning. He presently advises corporations around the world on negotiation strategy. 

Professor Ric Marshall, Former Director of Pricing, Monitor

MarshallIGHI Visiting Professor

Trained as an epidemiologist and clinical psychologist, Professor Marshall recently retired as Director of Pricing at Monitor. In this position, Professor Marshall worked very closely with the NHS in England to determine national prices for NHS services.

Professor Marshall has a wealth of international experience and has managed and advised on health information development in Azerbaijan, Canada, China, Egypt, FYR Macedonia, Georgia, Germany, Indonesia, Kosovo, Lithuania, Malaysia, Mauritius, the Phillippines, Qatar, Romania, Serbia, Slovenia and Turkey. 

Professor Marshall is also an Honorary Professor with the Faculty of Health Science at the University of Sydney in Australia, specialising in Health Service Management Information Development. 

Professor Stephen Matlin, Former Executive Director, Global Health Forum for Health Research

Stephen MatlinIGHI Adjunct Professor

Stephen was Executive Director of the Global Forum for Health Research in Geneva, 2004-2009. Educated at Imperial College, London as an organic chemist, Stephen worked in academia for over 20 years, with research, teaching and consultancy interests in medicinal, biological and analytical chemistry. This was followed by periods as Director of the Health and Education Division in the Commonwealth Secretariat, as Chief Education Adviser at the UK Department for International Development and as a freelance consultant in health, education and development.

He is currently a special adviser to the International Organization for Chemical Sciences in Development, a member of the Steering Committee of the Netherlands’ Global Health Policy and Health Systems Research Programme and co-chair of the Task Force of Global Health Europe.

Medical Director, Imperial College Healthcare NHS Trust

IGHI Visiting Professor

Dr Mitchell qualified in medicine from Cambridge University and the Middlesex Hospital and went on to train in general and respiratory medicine at the Middlesex, Hammersmith, University College, the London Chest and the Royal Brompton hospitals. He was then appointed as senior lecturer and honorary consultant in respiratory and general medicine to St Mary's Hospital Medical School and later, switched to the NHS. He served as clinical director for medicine before being appointed as medical director to the Trust.

Dr Brendan Moran, Consultant Colorectal Surgeon

Brendan MoranIGHI Visiting Professor

Dr Brendan Moran has been working at BMI The Hampshire Clinic since 1995 as a Consultant Colorectal Surgeon and General Surgeon. Mr Moran has been a Consultant Surgeon at the Basingstoke and North Hampshire Foundation Trust since 1995 and is now National Lead Clinician for the Low Rectal Cancer National Development Pilot Programme. Until this latest appointment, he was the Director of the UK Pseudomyxoma Peritonei National Centre, having developed the centre into the largest peritoneal malignancy treatment centre in the world.

Other principal appointments include Honorary Senior Clinical Lecturer at the University of Southampton, Cancer Sciences Division, Member of Council of the Association of Coloproctology of Great Britain and Ireland, Lead Surgeon of the National Multidisciplinary Team and the TME Development Programme. Dr Moran undertook his Registrar training in Hampshire and became a Fellow of the Royal College Of Surgeons of Ireland in 1984 and of England in 1997. Particular interests of Dr Moran include, rectal cancers, appendiceal tumours, Pseudomyxoma Peritonei.

Michel Mossessian, Architect, Mossessian Architecture

Michel IGHI Visiting Professor

Michel Mossessian is Design Principal at Mossessian Architecture, an international, award-winning architecture practice. Mossessian Architecture is committed to architecture that adds cultural value and benefits society ‘beyond buildings’.

Michel Mossessian launched the practice in London in 2005 to focus on the demands of complex, high-density urban spaces. His design process is entirely collaborative, alert to the needs of clients and attentive to the requirements of all stakeholders.

His own experience heading design at SOM London involved high level projects in Chicago, New York, Paris, and London, including leading the design team that won the competition for the new NATO Headquarters in Brussels. 

Sir David Nicholson, Former Chief Executive, NHS England

David NicholsonIGHI Adjunct Professor

Sir David was appointed Chief Executive of NHS England, formerly known as the NHS Commissioning Board, in October 2011. Up until April 2013, when NHS England took on its full powers, Sir David was also Chief Executive of the National Health Service (NHS) in England, a role he had held since September 2006. Sir David’s career in the NHS spans over 30 years. He started in the service as a management trainee, having graduated from the University of the West of England. He has held senior leadership positions in acute and mental health services, and at four regional health authorities. He was awarded the CBE in 2004 and was knighted in 2010, both for his services to the NHS.

Baroness Lindsay Northover, Liberal Democrat Principal Parliamentary Spokesperson on International Development, UK Parliament

Lindsay NorthoverIGHI Visiting Professor

After an early career in academia, Baroness Lindsay Northover was created a life peer in 2000 and has since been heavily involved in the House of Lords. From 2000 to 2002, she served as the Liberal Democrats Health Spokesperson in the House of Lords, and from 2002 to 2010 as the main frontbench Liberal Democrats Spokesperson on International Development.

In 2010, Baroness Northover was appointed Baroness-in-Waiting (Government Whip) and Spokesperson on International Development, Health, Justice and Women and Equalities, and later covered Education, DCMS and DEFRA (instead of Justice and Health). More recently, Baroness Northover served as the Parliamentary Under Secretary of State for the Department for International Development from November 2014 to May 2015. She is now the Liberal Democrat Principal Parliamentary Spokesperson on International Development.

Sir John Oldham, Former Quest for Quality and National Clinical Lead for Long Term Conditions

John OldhamIGHI Adjunct Professor

Qualified at Manchester Medical School in 1978 and worked in various teaching hospitals, culminating as a GP trainee in inner city Manchester.  He joined Manor House Surgery, Glossop in 1983, and becoming senior partner in 1988.

In 1992, he gained an MBA with Distinction from Manchester Business School; his dissertation was on Continuous Quality Improvement in Primary Health Care. The work in the practice led to him being asked to present a paper to the 1st European Forum on quality improvement in health care, and subsequent invitations to the US and Sweden.

Don Berwick, CEO Institute of Health Care Improvement invited him in 1997, to be on a national project group with the IHI in Boston, U.S.A., looking at redesigning surgery systems in the U.S. This was being done using the Collaborative method, which he then brought back to the UK.  He first proposed a primary care collaborative in 1997 and ultimately this led to him being asked to create and head the National Primary Care Development Team, which launched in February 2000.   

The Primary Care Collaborative was the largest improvement programme in the world covering 32 million patients in 40 months and delivering 72% improvement in access to GPs and substantial reductions in mortality to patients with CHD.  John Oldham also created the concept of the award winning Healthy Communities Collaborative with residents of deprived areas as the improvement team members.  This concept spread as Passion for Life throughout Scandinavia. He has also worked in Education, raising performance of underperforming pupils. He was invited by the Australian Government to design and train a team operate a Primary Care collaborative across the whole of Australia, and similarly Saskatchewan in Canada. He is a keynote speaker at many international conferences on quality and safety and has also presented at the World economic Forum in Davos. .  He has written a couple of books and numerous articles on quality improvement and large system change, and has been a visiting professor at Vanderbilt University, Tennessee.  He was National Clinical Lead for Quality and Productivity at the Department of Health and for 6 years was a member of the National Quality Board, setting the strategic direction for quality and safety in the NHS. He was Chair of Primary Care at the Global Health Forum presided by Lord Ara Darzi, and Chair of Independent Commission on Whole Person Care whose report One Person One Team One System was widely praised. He has recently assisted Norwegian ministers in Health strategy, Primary Care redesign in Sweden and a Maternity review in the NHS. He is also adjunct professor of Global health Innovation at Imperial College London.

In 2000, he received the OBE for services to patients and in 2003 was awarded a knighthood for services to the NHS.

Dr William Owen, Former CEO, Sidra Medical and Research Centre

OwenIGHI Visiting Professor

Dr William F Owen, Jr, MD, FACP, is an internationally experienced, academic health system leader with a balance of strategic vision and operational accumen. Under the patronage Her Highness Sheikha Moza bint Nasser, wife of the former Emir of Qatar, Dr Owen served as inaugural CEO of Sidra Medical & Research Center from 2012-14. Sidra is a unique tertiary/quaternary care health system for the women and children of the Middle East and North Africa and is Cornell University’s international academic health system affiliate.

Dr Owen’s academic career began as Instructor at Harvard Medical School in 1988, where he rose to Director of the nationally ranked Chronic Kidney Disease Program at Harvard’s Brigham and Women’s Hospital. In 1999, he joined Duke University and became a tenured Professor. At Duke, he was founding Director of a health services research and policy Institute that crossed Departments. From 2002-05, he was global Chief Scientist of Baxter International’s (Fortune 200) renal business and a Senior Scholar in Health Sector Management at Duke’s Fuqua Business School.

Dr Owen became the 10th Chancellor of the Health Science Center and Sr Vice President of Health Affairs at the University of Tennessee in 2005, and so became the first African-American to lead a public flagship, research health system. In 2007, he was appointed 5th President of the University of Medicine and Dentistry of New Jersey, then the US’ largest freestanding health university system and now the academic health system of Rutgers University, The State University of NJ.

Dr Colin Price, Executive Vice President and Global Managing Partner of the Leadership Consulting Practice, Heidrick & Struggles’ London Office

Colin PriceIGHI Visiting Professor

Colin Price is the Executive Vice President and Global Managing Partner of the Leadership Consulting Practice and based in Heidrick & Struggles’ London office. Prior to joining Heidrick & Struggles, Colin served as chairman of Co Company, an organisational development consulting firm acquired by Heidrick & Struggles in 2015.

He previously led the worldwide organisation practice at McKinsey & Co. for many years. Colin has consulted with many of the world’s largest organisations and published on important business challenges of organisation health and performance for 25 years. His focus is on developing organisations that can align, execute, and renew better and quicker than competitors. His body of work around building organisational health, purpose, culture, leadership, and capabilities has defined this arena of study and practice. Colin has published widely, and is author and co-author of seven books, including Beyond Performance: How Great Organisations Build Ultimate Competitive Advantage, with Scott Keller of McKinsey & Co. This book draws on the most exhaustive research effort of its kind on organisational effectiveness and change management. The research demonstrates that the health of an organisation is equally as important as its performance. 

Dr Santosh Rath, Honorary Professional Fellow of Global Surgery, University of Oxford

IGHI Visiting Professor

Dr Santosh Rath has led a distinguished twenty-year career as an orthopaedic surgeon and rehabilitation specialist, mainly in India where resources are scarce, yet complex problems persist, particularly following leprosy, spinal cord injuries, polio deformities and injuries. From 2005-2012, Dr Rath was a Professor and Head of the Post Graduate Department of Orthpedics at Hi-tech College Bhubaneswar.

More recently, Mr Rath has held positions in the UK, including as a Visiting Fellow at the International Centre for Evidence in Disability at the London School of Hygiene and Tropical Medicine, and as a Professorial Fellow in Global Surgery at the George Institute of Global Health at the University of Oxford.

Dr Julia Riley, Consultant in Palliative Medicine, Royal Marsden and Royal Brompton Hospitals

Julia RileyIGHI Visiting Professor

Dr Julia Riley is head of the Department of Palliative Medicine at The Royal Marsden and the Royal Brompton Hospital, and a senior research fellow at Imperial College London. She is also Chair of the Supportive and Palliative Care Group South West London, a member of the NICE consideration panel for cancer, a member of the executive committee of the Association for Palliative Medicine and Editor of the European Journal of Palliative Care (the journal of the European Association for Palliative Care).

Dr Riley has two main research interests. The first is in the inter-individual variation in patients’ response to opioids. The second is the development of models of end-of-life care that involve a seamless transition between the acute and the community sector, improve quality of life, decrease the number of unnecessary hospital admissions and increase the number of patients being cared for and dying in their preferred place.

Baroness Royall of Blaisdon

Baroness RoyallIGHI Visiting Professor

In June 2004, Janet Royall was created Baroness Royall of Blaisdon, of Blaisdon in the County of Gloucestershire. In the House of Lords, she became government spokesperson for Health, International Development and Foreign and Commonwealth Affairs.

In January 2008 Baroness Royall was appointed government chief whip in the House of Lords, following the resignation of Lord Grocott. She was appointed a Privy Counsellor later in the year. In October 2008, she was promoted to the cabinet by Gordon Brown, who made her Leader of the House of Lords and Lord President of the Council. In June 2009, Royall was succeeded as Lord President by Lord Mandelson, the Business Secretary, and was appointed Chancellor of the Duchy of Lancaster.

Professor Richard Satava, Professor, Department of Surgery, University of Washington

Richard SatavaIGHI Visiting Professor

Richard Satava, MD, FACS, is Professor of Surgery at the University of Washington Medical Center, and Senior Science Advisor at the US Army Medical Research and Materiel Command in Ft. Detrick, MD.

Prior positions include Professor of Surgery at Yale University and a military appointment as Professor of Surgery (USUHS) in the Army Medical Corps assigned to General Surgery at Walter Reed Army Medical Center and Program Manager of Advanced Biomedical Technology at the Defense Advanced Research Projects Agency (DARPA),

He has served on the White House Office of Science and Technology Policy (OSTP) Committee on Health, Food and Safety. He is currently a member of the Emerging Technologies and Resident Education, and Informatics committees of the American College of Surgeons (ACS), is past president of the Society of American Gastrointestinal Endoscopic Surgeons (SAGES), past president of the Society of Laparoendoscopic Surgeons (SLS), and is on the Board of Governors of the National Board of Medical Examiners (NBME) as well as on a number of surgical societies. He is on the editorial board of numerous surgical and scientific journals, and active in numerous surgical and engineering societies.

Professor Jeffrey Shaw, Honorary Professor at Central Academy of Fine Art, Beijing, Dean of School of Creative Media, City University of Hong Kong

Jeffrey ShawIGHI Visiting Professor

Professor Shaw has demonstrated signific ant impact wi thin his profession and work practice as a leader in the field of digital media technologies.

He has been a leading figure in new media art since its emergence from the performance, expanded cinema and installation paradigms of the 1960s to its present day technology-informed and virtualised forms. In a prolific career of widely exhibited and critically acclaimed work, he has pioneered the creative use of digital media technologies in the fields of virtual and augmented reality, immersive visualisation environments, navigable cinematic systems and interactive narrative.

Professor Shaw was co-founder of the Eventstructu re Research Group in Amsterdam ( 1969-1979), a nd founding director of the ZKM Institute for Visual Media Karlsruhe (1991-2002). At the ZKM he conceived and ran a seminal artistic research program that included the ArtIntAct series of digital publications, the MultiMediale series of international media art exhibitions, over one hundred artist-in-residence proj ects, and t he invention of new creative platforms such as the EVE Extended Virtual Environment (1993) PLACE (1995) and the P anoramic Navig ator (1997). In 1995 Shaw was appointed Professor of Media Art at the State University of Design, Media and Arts (HfG), Karlsruhe, Germany.

In 2003, Professor Shaw was awarded the prestigious Australian Research Council Federation Fellowship and returned to Australia to co-found and direct the UNSW iCinema Centre for Interactive Cinema Research in Sydney from 2003-2009. At iCinema he led a theoretical, aesthetic and technological research program in immersive interactive post-narrative systems, which produced pioneering artistic and research works such as Place-Hampi and T_Visionarium, the latter shown at the Biennale of Seville in 2008.

In 2009 he joined City University in Hong Kong as Chair Professor of Media Art and Dean of the School of Creative Media (SCM).

Dr Richard Smith, Director, UnitedHealth Chronic Disease Initiative and former Editor of the BMJ

Richard SmithIGHI Visiting Professor

Richard Smith is Director of the UnitedHealth Chronic Disease Initiative which has collaborated with the National Heart, Lung, and Blood Institute to create centres in the developing world to reduce the burden of Non-Communicable Disease. Previously he was Editor of the British Medical Journal and Chief Executive of the BMJ Publishing Group. He is Chair of the board of ICDDR,B (formerly International Centre for Diarrhoeal Disease Research, Bangladesh), an Adjunct Professor at Imperial’s Institute of Global Health Innovation and Chair of the board of Patients Know Best (a start up that uses IT to improve patient clinician partnership).

Dr Suzanne Suggs, Associate Professor, University of Lugano

Suzanne SuggsIGHI Visiting Reader

Professor Suggs is an Associate Professor of Social Marketing and Head of the BeCHANGE Research Group in the Institute for Public Communication, Faculty of Communication Sciences, at the University of Lugano in Switzerland. She is also Director of the USI Sustainability Incubator (USI-SINC). She received a BBA in Marketing at University of North Texas (USA), a MSc and PhD in Health Studies at Texas Woman’s University (USA), and a Post-doctoral fellowship at McMaster University (Canada).

Suzanne’s research focuses on behavior change communication through information and communication technologies. She examines the determinants of behavior and tests innovative digital communication strategies, delivered through ICT, and the influence on health behaviors. The majority of her work focuses on eating and physical activity behaviors, but also does research on alcohol, tobacco, decision-making, vaccination uptake, hand washing, HIV testing, medication compliance, self-management of conditions and therapy, and consumption behaviors.

Prior to joining the faculty in Lugano, she was Assistant Professor of Health Communication, Department of Marketing Communication, at Emerson College and Adjunct Assistant Clinical Professor in the Department of Public Health and Family Medicine at Tufts University School of Medicine (Boston, Massachusetts, USA). 

Dr Suggs is also Associate Editor of Global Health Communication and on the Editorial Review Board of the Journal of Health Communication. 

Dr Paul Thompson, Rector of the Royal College of Art and former Director, National Design Museum, New York City

Paul ThompsonIGHI Adjunct Professor

Dr Paul Thompson is the Vice-Chancellor of the Royal College of Art, the world’s oldest art school in continuous operation, and the only art and design university in the UK operating exclusively at postgraduate level. In 2015, 2016 and 2017, the RCA was ranked the world’s number one art and design university in the QS World University Rankings.

Prior to 2009, Paul was Director of the Smithsonian’s Cooper-Hewitt, National Design Museum in New York from 2001-2009. He was Director of the Design Museum in London from 1993-2001 and was educated at the Universities of Bristol and East Anglia. He is an Adjunct Professor at the Innovation in Global Health Institute, Imperial College London, a Trustee of the Victoria & Albert Museum and is on the Ashmolean Museum Board of Visitors.

Dr Agis Tsouros, International Advisor, Health Policy and Strategy and former Director of Policy and Governance for Health and Wellbeing at WHO

DR AGIS TSOUROSIGHI Visiting Professor

Dr Tsouros is a  leading international expert with 30 years of experience in the fields of health promotion, policy and systems and is well known internationally for his innovative work, his public health leadership and his diplomatic and communication skills. As former Director of the Division of Policy and Governance for Health and Wellbeing at the WHO Regional Office for Europe, he was responsible for the implementation of the new European Health Policy - Health 2020 and had leadership responsibility for a range of areas, including health policies; co-ordination and reform of the country health department; urban health and healthy cities; health promotion, healthy ageing and public health functions and infrastructures. During the period 2004 to 2006 he was seconded to the Greek Ministry of Health and assumed the position of Chairman of the National Board of Public Health and President of the Greek CDC. He is the author of many influential publications, which and have been translated into many languages worldwide. Dr Tsouros has collaborated with all 53 countries of the European region and worked in close cooperation with several directorates-general including those of the European Commission and the Council of Europe.

Sir Andrew Whitty, CEO, Glaxosmithkline (GSK)

Andrew WhittyIGHI Visiting Professor

Andrew became Chief Executive Officer of GlaxoSmithKline plc on 21 May 2008. He is a member of the Board and Corporate Executive Team.

Andrew joined Glaxo in 1985 and has held a variety of Sales and Marketing roles in the UK and abroad including working in the Company’s International New Products groups, both in the Respiratory and HIV/Infectious disease fields.  Outside of the UK Andrew has worked in South Africa, the USA and Singapore where he led the Group’s operations as Senior Vice President, Asia Pacific. While in Singapore Andrew was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star.

In 2003 Andrew was appointed President of GSK Europe and joined GSK’s Corporate Executive Team.

Andrew has served in numerous advisory roles to Governments around the world including South Africa, Singapore, Guangzhou China and the UK, where he was a member of the Prime Minister’s Business Advisory Group from 2010 - 2015.  He was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry in the 2012 New Year Honours List. In 2014, Andrew was appointed to be a Business Ambassador for the UK Government and in 2015, Andrew became a member of the China-Britain Business Council Advisory Council.

Andrew is Chancellor of the University of Nottingham, a position he took up on 1 January 2013.

Andrew has a Joint Honours BA in Economics from the University of Nottingham.